Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lubiprostone Equivalence in Chronic Idiopathic Constipation
NCT01372423Phase 3Completed
- Sponsor
- Anchen Pharmaceuticals, Inc.
- Start
- May 2011
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cobiprostone in chronic idiopathic constipation (CIC) (3 arms), sponsored by Anchen Pharmaceuticals, Inc. Primary endpoint: Primary Analysis at Day 8. Started May 2011; status: completed.
02
Drugs
cobiprostone
03
Conditions
chronic idiopathic constipation (CIC)
Beyond the preview
Go deeper on NCT01372423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01372423.